You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Montanide

Showing 201 - 225 of 229
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia, Minimal Residual Disease Trial in Houston (Synthetic Tumor-Specific Breakpoint Peptide Vaccine)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Minimal Residual Disease
  • Synthetic Tumor-Specific Breakpoint Peptide Vaccine
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 1, 2012

Esophageal Cancer Trial in 2-11-1 Kaga Itabashi-ku (URLC10, TTK, KOC1, VEGFR1, VEGFR2, cisplatin, fluorouracil)

Unknown status
  • Esophageal Cancer
  • URLC10, TTK, KOC1, VEGFR1, VEGFR2, cisplatin, fluorouracil
  • 2-11-1 Kaga Itabashi-ku, Tokyo, Japan
    Teikyo University
Jul 20, 2011

Melanoma (Skin) Trial in United States (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +5 more
  • Scottsdale, Arizona
  • +31 more
Nov 5, 2011

Leukemia Trial in Portland (bcr-abl peptide vaccine, reverse transcriptase-polymerase chain reaction)

Terminated
Has Results
  • Leukemia
  • bcr-abl peptide vaccine
  • reverse transcriptase-polymerase chain reaction
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 31, 2011

Prostate Cancer Trial in Morioka (CDCA1)

Unknown status
  • Prostate Cancer
  • CDCA1
  • Morioka, Iwate, Japan
    Iwate Medical University School of Medicine
Jun 22, 2011

Bladder Cancer Trial in Morioka (MPHOSPH1 and DEPDC1)

Unknown status
  • Bladder Cancer
  • MPHOSPH1 and DEPDC1
  • Morioka, Iwate, Japan
    Iwate Medical University School of Medicine
Jun 22, 2011

Pancreatic Cancer, Pancreas Tumors Trial in Minato-ku (HLA-A*02:01-restricted VEGFR1-derived peptide vaccination)

Terminated
Has Results
  • Pancreatic Cancer
  • Pancreas Neoplasms
  • HLA-A*02:01-restricted VEGFR1-derived peptide vaccination
  • Minato-ku, Tokyo, Japan
    Research Hospital, The Institute of Medical Science, The Univers
Jul 20, 2011

Ovarian Cancer Trial in Groningen (P53-SLP vaccine, Cyclophosphamide)

Completed
  • Ovarian Cancer
  • Groningen, Netherlands
    University Medical Centre Groningen
Feb 24, 2011

Esophageal Cancer Trial in 811-1 Kimiidera, Wakayama (URLC10-177, TTK-567, CpG-7909)

Unknown status
  • Esophageal Cancer
  • URLC10-177, TTK-567, CpG-7909
  • 811-1 Kimiidera, Wakayama, Wakayama, Japan
    Wakayama Medical University Hospital
Sep 8, 2010

Bladder Cancer Trial in Morioka (MPHOSPH1 and DEPDC1)

Completed
  • Bladder Cancer
  • MPHOSPH1 and DEPDC1
  • Morioka, Iwate, Japan
    Iwate Medical University School of Medicine
Oct 20, 2010

Plasmodium Falciparum Malaria Trial in Lausanne (PfCS102, Montanide ISA 720)

Completed
  • Plasmodium Falciparum Malaria
  • PfCS102
  • Montanide ISA 720
  • Lausanne, Switzerland
    Department of Ambulatory Care and Community Medicine; University
Dec 11, 2009

Breast Cancer Trial in Minato-ku (VEGFR1 and VEGFR2)

Terminated
  • Breast Cancer
  • VEGFR1 and VEGFR2
  • Minato-ku, Tokyo, Japan
    The Institute of Medical Science, the University of Tokyo
Dec 28, 2009

Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Minato-ku (VEGFR1 and VEGFR2)

Terminated
  • Colorectal Cancer
  • +2 more
  • VEGFR1 and VEGFR2
  • Minato-ku, Tokyo, Japan
    The Institute of Medical Science, The University of Tokyo
Dec 28, 2009

Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Minato-ku (RNF43, TOMM34, VEGFR1 and VEGFR2)

Terminated
  • Colorectal Cancer
  • +2 more
  • RNF43, TOMM34, VEGFR1 and VEGFR2
  • Minato-ku, Tokyo, Japan
    The Institute of Medical Science, the University of Tokyo
Dec 28, 2009

Esophageal Cancer Trial in 4-6-1, Shirokanedai, Minato-ku (URC10, TTK, KOC1)

Completed
  • Esophageal Cancer
  • URC10, TTK, KOC1
  • 4-6-1, Shirokanedai, Minato-ku, Tokyo, Japan
    The Institutute of Medical Science, University of Tokyo
Nov 18, 2009

Gastric Cancer Trial in 4-6-1, Shirokanedai, Minato-ku (URLC10, VEGFR1 and VEGFR2)

Completed
  • Gastric Cancer
  • URLC10, VEGFR1 and VEGFR2
  • 4-6-1, Shirokanedai, Minato-ku, Tokyo, Japan
    The Institutute of Medical Science, University of Tokyo
Nov 18, 2009

Esophageal Cancer Trial in 4-6-1, Shirokanedai, Minato-ku (URLC10, VEGFR1 and VEGFR2)

Completed
  • Esophageal Cancer
  • URLC10, VEGFR1 and VEGFR2
  • 4-6-1, Shirokanedai, Minato-ku, Tokyo, Japan
    The Institutute of Medical Science, University of Tokyo
Nov 18, 2009

Gastric Cancer Trial in 4-6-1, Shirokanedai, Minato-ku (URLC10, KOC1, VEGFR1 and VEGFR2)

Completed
  • Gastric Cancer
  • URLC10, KOC1, VEGFR1 and VEGFR2
  • 4-6-1, Shirokanedai, Minato-ku, Tokyo, Japan
    The Institutute of Medical Science, University of Tokyo
Nov 18, 2009

Pancreatic Cancer, Pancreas Tumors Trial in Minato-ku (VEGFR1-A24-1084 (SYGVLLWEI))

Unknown status
  • Pancreatic Cancer
  • Pancreas Neoplasms
  • VEGFR1-A24-1084 (SYGVLLWEI)
  • Minato-ku, Tokyo, Japan
    Research Hospital, The Institute of Medical Science, The Univers
May 6, 2009

Pancreatic Cancer Trial in 811-1 Kimiidera, Wakayama (VEGFR2-169 and gemcitabine)

Completed
  • Pancreatic Cancer
  • VEGFR2-169 and gemcitabine
  • 811-1 Kimiidera, Wakayama, Wakayama, Japan
    Wakayama Medical University Hospital
Feb 17, 2009

Plasmodium Falciparum Malaria Trial in Nijmegen, Rijswijk (PfAMA-1-FVO[25-545])

Completed
  • Plasmodium Falciparum Malaria
  • PfAMA-1-FVO[25-545]
  • Nijmegen, Netherlands
  • +1 more
Aug 7, 2008

Non Small Cell Lung Cancer Trial in Tokyo (URLC10, TTK and KOC1)

Unknown status
  • Non Small Cell Lung Cancer
  • URLC10, TTK and KOC1
  • Tokyo, Japan
    The Institute of Medical Science, The University of Tokyo
May 12, 2008

Non Small Cell Lung Cancer Trial in Tokyo (URLC10, VEGFR1 and VEGFR2)

Unknown status
  • Non Small Cell Lung Cancer
  • URLC10, VEGFR1 and VEGFR2
  • Tokyo, Japan
    The Institute of Medical Science, The University of Tokyo
May 12, 2008

Malaria Trial in Bandiagara (Malaria vaccine AMA1 (PfAMA-1-FVO[25-545], AMA1)

Unknown status
  • Malaria
  • Malaria vaccine AMA1 (PfAMA-1-FVO[25-545]
  • AMA1
  • Bandiagara, Mali
    Malaria Research and Training Center
Apr 1, 2008

Nasopharyngeal Tumors Trial run by the CC (EBV-LMP-2)

Completed
  • Nasopharyngeal Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center (CC)
Mar 3, 2008